These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36707997)

  • 1. Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study.
    Lam TO; Cheng IT; Lam SH; Mok CC; Ho CT; Cheung TT; Lao VW; Pang HT; To CH; Yim CW; Ng A; Kwok KY; Lee KL; Ying SK; Wan MC; Lee JM; Tam LS
    Rheumatology (Oxford); 2023 Sep; 62(9):2998-3005. PubMed ID: 36707997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.
    Innala L; Möller B; Ljung L; Magnusson S; Smedby T; Södergren A; Öhman ML; Rantapää-Dahlqvist S; Wållberg-Jonsson S
    Arthritis Res Ther; 2011 Aug; 13(4):R131. PubMed ID: 21843325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up.
    Martín-Martínez MA; Castañeda S; Sánchez-Alonso F; García-Gómez C; González-Juanatey C; Sánchez-Costa JT; Belmonte-López MA; Tornero-Molina J; Santos-Rey J; Sánchez González CO; Quesada E; Moreno-Gil MP; Cobo-Ibáñez T; Pinto-Tasnde JA; Babío-Herráez J; Bonilla G; Juan-Mas A; Manero-Ruiz FJ; Romera-Baurés M; Bachiller-Corral J; Chamizo-Carmona E; Uriarte-Ecenarro M; Barbadillo C; Fernández-Carballido C; Aurrecoechea E; Möller-Parrera I; Llorca J; González-Gay MA;
    Rheumatology (Oxford); 2021 Jun; 60(6):2906-2915. PubMed ID: 33254222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study.
    Agca R; Hopman LHGA; Laan KJC; van Halm VP; Peters MJL; Smulders YM; Dekker JM; Nijpels G; Stehouwer CDA; Voskuyl AE; Boers M; Lems WF; Nurmohamed MT
    J Rheumatol; 2020 Mar; 47(3):316-324. PubMed ID: 31092721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Methotrexate Use and the Risk of Cardiovascular Events in Patients with Elderly-onset Rheumatoid Arthritis.
    Widdifield J; Abrahamowicz M; Paterson JM; Huang A; Thorne JC; Pope JE; Kuriya B; Beauchamp ME; Bernatsky S
    J Rheumatol; 2019 May; 46(5):467-474. PubMed ID: 30504508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comorbidities-Their role in the treat to target concept for rheumatoid arthritis].
    Krüger K; Kneitz C
    Z Rheumatol; 2019 Jun; 78(5):422-428. PubMed ID: 31049664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis.
    Sattui SE; Rajan M; Lieber SB; Lui G; Sterling M; Curtis JR; Mandl LA; Navarro-Millán I
    Semin Arthritis Rheum; 2021 Feb; 51(1):292-298. PubMed ID: 33433365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group.
    Cacciapaglia F; Spinelli FR; Piga M; Erre GL; Sakellariou G; Manfredi A; Viapiana O; Fornaro M; Colella S; Floris A; Mangoni AA; Castagna F; Vacchi C; Orsolini G; Bugatti S; Cafaro G; Cauli A; Gremese E; Atzeni F; Bartoloni E
    Eur J Intern Med; 2022 Feb; 96():60-65. PubMed ID: 34657778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and predictors of cardiovascular events in a cohort of patients with rheumatoid arthritis.
    Castro AM; Carmona-Fernandes D; Rodrigues AM; Pedro LM; Santos MJ; Canhão H; Fonseca JE
    Acta Reumatol Port; 2016; 41(3):213-219. PubMed ID: 27682808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.
    Naranjo A; Sokka T; Descalzo MA; Calvo-Alén J; Hørslev-Petersen K; Luukkainen RK; Combe B; Burmester GR; Devlin J; Ferraccioli G; Morelli A; Hoekstra M; Majdan M; Sadkiewicz S; Belmonte M; Holmqvist AC; Choy E; Tunc R; Dimic A; Bergman M; Toloza S; Pincus T;
    Arthritis Res Ther; 2008; 10(2):R30. PubMed ID: 18325087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis.
    Párraga Prieto C; Ibrahim F; Campbell R; Chinoy H; Galloway J; Gordon P
    Clin Rheumatol; 2021 Jan; 40(1):231-238. PubMed ID: 32572804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting.
    An J; Cheetham TC; Reynolds K; Alemao E; Kawabata H; Liao KP; Solomon DH
    Arthritis Care Res (Hoboken); 2016 May; 68(5):629-37. PubMed ID: 26414069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.
    Solomon DH; Kremer J; Curtis JR; Hochberg MC; Reed G; Tsao P; Farkouh ME; Setoguchi S; Greenberg JD
    Ann Rheum Dis; 2010 Nov; 69(11):1920-5. PubMed ID: 20444756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rheumatoid arthritis: a cardiovascular disease?].
    Daïen CI; Fesler P
    Ann Cardiol Angeiol (Paris); 2012 Apr; 61(2):111-7. PubMed ID: 21885031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.
    Jafri K; Bartels CM; Shin D; Gelfand JM; Ogdie A
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):51-57. PubMed ID: 27696731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint Destruction Is Associated With All Types of Cardiovascular Events in French Rheumatoid Patients: A Real-Life Study With Very Long Follow-Up.
    Robert M; Hot A; Mifsud F; Ndongo-Thiam N; Miossec P
    Front Med (Lausanne); 2020; 7():556086. PubMed ID: 33195306
    [No Abstract]   [Full Text] [Related]  

  • 18. Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events.
    Ajeganova S; Andersson MLE; Frostegård J; Hafström I
    Arthritis Res Ther; 2021 Jul; 23(1):201. PubMed ID: 34311770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
    Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008.
    Kerola AM; Nieminen TV; Virta LJ; Kautiainen H; Kerola T; Pohjolainen T; Kauppi MJ; Puolakka K
    Clin Exp Rheumatol; 2015; 33(3):391-8. PubMed ID: 25936374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.